| Particulars |
|
|
|
| Company Name
| Dr Reddys Laboratories Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
83.47 |
B.V. (₹) |
375.80 |
| Sales(₹ Cr.) |
20,460.60 |
NP (₹ Cr.) |
3,219.70 |
| NP Var% |
-40.00 |
Div% |
800.00 |
| CPS(₹) |
53.00 |
EPS (₹) |
38.60 |
| Traded Value(₹ Lakhs) |
905.04 |
52 Week High |
1,376.00 |
| 52 Week Low |
1,149.00 |
Price BSE |
1,291.00 |
| Price NSE |
1,291.00 |
Market Capital (₹ Cr.) |
107,760.82 |
| P/C Ratio |
24.30 |
P/E Ratio |
33.50 |
| Price Vs.BV |
3.44 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
3,802.60 |
| NP(₹ Cr.) |
-219.40 |
NP Var % |
-118.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
21,667.60 |
| OPM |
30.97 |
NP |
4,809.30 |
| NP Var% |
-40.17 |
EPS |
38.57 |
| PE |
33.47 |
|
|